Trial intelligence / Profile preview

MRX-7EAT Patch in Ankle Sprains

NCT01198834Phase 3Completed

Sponsor
MEDRx
Start
Sep 2010
Primary completion
Jun 2011
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial of etodolac and lidocaine in Ankle sprain (4 arms), sponsored by MEDRx. Primary endpoint: Mean of All Current Pain Intensity During Point and Flex Scores on Days 2 Through 7. Started Sep 2010; status: completed.

02

Drugs

etodolaclidocaine
03

Conditions

Ankle sprain

Beyond the preview

Go deeper on NCT01198834.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01198834.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call